(Heskumdai wrote) I've always had the uneasy feeling that...

(Heskumdai wrote) I've always had the uneasy feeling that Phenomica is essentially a competitor to Phylogica

Phenomica is a licensee of Phylogica technology.

They are very far from being a competitor - they are building upon:

- Phylomer discovery patents;
- Phylomer screening technologies and patents; and
- (possibly) application of the EET technologies.

The value that they may be adding is:

- A computational framework for analysis of the cancer cells of an individual (not just a tissue type, but the tissue type of an individual) - identify a unique target;

- Mapping this to a set of proteins that become the "missile guidance system"

The value that we add is:

- We can build and test the "missile" and provide the "explosive device" that works with the Phenomica targeting system.

At this point in time, it looks like our Phylomer and screening technologies are the best in the world, for this application (judged by the best in the world - the Hutchison/MRC Research Centre).